Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

PFMT remains first choice over duloxetine in stress incontinence

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    PFMT remains first choice over duloxetine in stress incontinence. Pharmacoecon. Outcomes News 506, 6 (2006). https://doi.org/10.2165/00151234-200605060-00014

    Download citation

    Keywords

    • Urinary Incontinence
    • Economic Evaluation
    • Markov Model
    • Outcome News
    • Stress Urinary Incontinence